LivaNova PLC (LIVN)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $5.03B
Last updated: Nov 17, 2026 at 11:06 AM ET
LivaNova PLC (LIVN) P/E Ratio & Valuation History
LivaNova (LIVN) trades at 23.8x trailing earnings and 3.5x sales. Its P/E of 23.8x is above its 5-year median of 18.8x. Its forward P/E is 18.8x. The median P/E across 9 similar companies is 23.9x.
Current Multiples
Its forward P/E is below its trailing P/E, which implies earnings per share about 26.6% higher over the next year. Its free cash flow yield is 2.4%.
| Multiple | Value |
|---|---|
| P/E (trailing) | 23.8x |
| Forward P/E | 18.8x |
| Price to sales | 3.5x |
| Price to book | 3.9x |
| EV/EBITDA | 23.9x |
| Price to FCF | 41.1x |
| EV/FCF | 39.1x |
| PEG | 0.9 |
| FCF yield | 2.4% |
Historical Medians
Against its 10-year medians, its P/E is 10.2% above 21.6x, its P/S is 25.0% above 2.8x and its P/B is 62.5% above 2.4x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/E | 23.8x | 18.8x | 21.6x |
| P/S | 3.5x | 2.5x | 2.8x |
| P/B | 3.9x | 2.5x | 2.4x |
Valuation History
Over the 10 year ends shown, its P/E ranged from 13.7x in 2024 to 52.1x in 2020.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $61.53 | 16.4x | 2.4x | 2.8x |
| 2024 | $46.31 | 13.7x | 2.0x | 1.9x |
| 2023 | $51.74 | 18.4x | 2.4x | 2.2x |
| 2022 | $55.54 | 23.1x | 2.9x | 2.5x |
| 2021 | $87.43 | 41.2x | 4.3x | 3.6x |
| 2020 | $66.21 | 52.1x | 3.4x | 2.9x |
| 2019 | $75.43 | 24.5x | 3.4x | 2.6x |
| 2018 | $91.47 | 25.8x | 4.0x | 3.0x |
| 2017 | $79.92 | 22.6x | 3.2x | 2.1x |
| 2016 | $44.97 | 17.8x | 1.8x | 1.3x |
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About LIVN
What is LIVN's forward P/E ratio?
LivaNova has a forward P/E ratio of 18.8x.
Is LIVN stock overvalued?
GNG's valuation label for LIVN is Fairly valued. Its P/E of 23.8x compares with a median of 23.9x across 9 similar companies.
What is LIVN's price to sales ratio?
LivaNova has a price to sales ratio of 3.5x.
What is LivaNova's average P/E ratio over 5 years?
LivaNova's median P/E over the last 5 years is 18.8x, from 60 month-end values through Oct 2026.
What is LIVN's PEG ratio?
LivaNova has a PEG ratio of 0.9.
LIVN pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts